Jump to:

Philip Morris

Topic: Knowledge, Lung Cancer

Date: 18 Feb 1964 (est.)
Length: 3 pages
2025010486-2025010488
Jump To Images
snapshot_pm 2025010486-2025010488

Fields

Type
REPT, REPORT, OTHER
Area
LEGAL DEPT/CARLSTADT
Master ID
2025010486/0498

Related Documents:
Request
Stmn/R1-004
Named Person
Cullman, H.
Wakeman, H.
Document File
2025010421/2025010729/Cipollone - Trial Issues PM Research
Litigation
Stmn/Produced
Named Organization
Sgc, Surgeon General's (Advisory) Comm
TI, Tobacco Inst
TIRC, Tobacco Industry Research Comm
Site
N28
Date Loaded
05 Jun 1998
UCSF Legacy ID
jig24e00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: jig24e00
Paze 9 SE 7'57 Topic: F:nowledze, Lun, Cancer Title: Sr'c•king and Health: Sicr.i°icance of the Rep---r` of the S.:_ceor. Genera?'s Cor._.ittee to Philip N.c_ris Ircorp:.r_tc-1 A:.th^- k:.keha:-., H. I Recioier.t: Cull!man, H. and others Pate: Februar•,• 18, 1964 Docu*'e-: Location: Internal Report 5f- Co-,e^_s and Quotes: This doc.::-.ent responds dire__iy the e es:io- "K!:a: did you do in respo nse to reports that cig,_e.te s-.c}:in_ 'caused' l;:ne cancer and other health probl'.e:-:s:" ^:F e-=irc docu.nent should be read carefully, b:~t the flavor of it carn be discerned fror the follokinc quotes. The hcpe3-for result of these [re.:or-en--ced researct.; efforts will be cicaret=es with distincuishinc new prod•ict properties which are biolocically approved on all r.:aj: health a_es_ions. S.:z.`h p:o3„c_s sho-.:ld be a--,ertise: vioorously on the basis of studies so con-4.:cte--. HeaLth impact wil I s,-:-ely be an ir.,p rtar.t , perhaps the most irpor_ant, basis for co-- pe:iltion in the ind.atry in the next few years. A special area of scientific activity recein•inoa growing atte ntion in the recent past and accorded emphasis in the report is that of p~:lrtonary clea nsing rec}:anisc.s, particularly cilia function. This to:?ether with respiratory effects of s:rokine ir. general, is due for increased scie nti`ic inquiry in the future. is
Page 2: jig24e00
[Recommendation to management] Adopt as internal policy for technical purposes the view that greater benefit will accrue from accepting the report's findings on face value and proceeding to the cure of ills, real and alleged as they may be, than from the engaging indisputation and refutation of these claims. [Recommendation to management] Move promptly and~effectively toward establish- ment of suitable biological approval specifications for all new smoking products. . . . Apart from possible legal requirements, such a polciy would enhance ad'vertising opportunities. [Recommendation to management] Provide a substantive basis for vigorous health advertising by publicati~on of suitable articles in the technical literature. Consideration~of the report's findings has resulted in the following influences on the Research Center program, to be acted on promptly: 1. A broad review of bioassay techniques . . will be undertaken to define optimum criteria for use in physiological studies, both at the Center and elsewhere. These criteria will include specifically a quick test for chemical carcinogenicity and best measures of pulmonary cleansing effectiveness . . . . 4. Present programs studying gas phase adsorption and tar fraction:carcinogenicity will be emphasized~, to improve competitive posture in these technical areas. t 01
Page 3: jig24e00
The value of filters is undersold in the report and is the industry's best extant answer to its problem. The Tobacco Institute obviously should foster the communication of the filter message by all effective means. [Goes on to specify recommendations of research to be sponsored by TIRC.] If it is true that the onus of proof in the Smoking and Health issue has shifted to the tobacco industry, then the industry must come forward with evidence to show that its products, present and prospective, are not harmful. . . The industry should~ aband'on its past reticence with respect to medical research. Indeed, failure to do such research could give rise to negligence charges. Further, it is not enough to sponsor the work of third parties .... Individual companies must also do their own research if they expect to develop proprietary positions for the health competition. I N 0 N ~ 0 N 0 ~ ~ ao

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: